Indorama Ventures Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Indorama Ventures han disminuido a una tasa media anual de -53.2%, mientras que en la industria Chemicals los beneficios crecieron en un 7.3% anualmente. Los ingresos han ido creciendo a una tasa media de 1.1% al año.
Información clave
-53.18%
Tasa de crecimiento de los beneficios
-53.18%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 8.05% |
| Tasa de crecimiento de los ingresos | 1.06% |
| Rentabilidad financiera | -5.98% |
| Margen neto | -2.21% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
IVL: Lower Discount Rate And Higher Future P/E Will Support Upside
Analysts have raised their price target on Indorama Ventures from THB 28.0 to THB 31.1 as they update their views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Board meeting scheduled for February 27, 2026 to consider convening the Annual General Meeting of Shareholders, which can shape upcoming decisions on dividends, capital allocation, and governance (Key Developments).
IVL: Higher Future P/E Assumptions Will Constrain Share Price Upside
Analysts have raised their price target for Indorama Ventures from THB17.54 to THB21.00, citing updated assumptions on the discount rate, revenue trajectory, profit margin, and future P/E multiples as key drivers of the change. What's in the News Board meeting scheduled for Feb 27, 2026, to consider convening the Annual General Meeting of Shareholders, which may shed light on upcoming resolutions and corporate priorities (Key Developments).IVL: Higher Assumed P/E And Softer Margins Will Restrain Future Returns
Analysts now set their price target for Indorama Ventures at about THB17.54, compared with the prior fair value estimate of about THB14.82. This reflects updated views on a lower discount rate, a smaller expected revenue decline, slightly softer profit margins, and a higher assumed future P/E multiple.
IVL: Green Chemistry And AI Will Shape Balanced Prospects Into 2026
Indorama Ventures' analyst price target has been adjusted slightly to THB 23.07 from THB 23.03, with analysts pointing to updated assumptions that include a different discount rate, higher modeled revenue growth, a lower profit margin, and a higher future P/E multiple. What's in the News Board meeting scheduled for Feb 27, 2026, with the agenda to consider convening the Annual General Meeting of Shareholders (Key Developments).IVL: Lower Discount Rate And Higher Future P/E Will Support Upside
Analysts have nudged their fair value estimate for Indorama Ventures slightly lower from THB 28.10 to THB 28.00, reflecting updated views around a reduced discount rate, higher assumed revenue growth, a slimmer profit margin, and a higher future P/E multiple. What's in the News Board meeting scheduled for Feb 27, 2026 to consider convening the Annual General Meeting of Shareholders, which can set the timetable for key shareholder decisions (Key Developments).IVL: Green Chemistry And AI Will Support Measured Future Return Potential
Analysts have trimmed their 12 month price target for Indorama Ventures slightly to THB23.03 from THB23.39, reflecting refreshed assumptions around the discount rate, revenue growth, profit margin and future P/E that point to only modest tweaks in their valuation views. What's in the News Indorama Ventures held an Analyst/Investor Day, which gave the market an opportunity to hear updated views and priorities directly from management (Key Developments).IVL: Lower Future P/E Multiple Will Limit Share Price Upside
Analysts have trimmed their price target for Indorama Ventures to approximately US$14.82 from about US$15.30, citing updated assumptions around discount rates, slightly different revenue expectations, improved profit margin forecasts, and a lower future P/E multiple. Valuation Changes Fair Value: Trimmed slightly from US$15.30 to about US$14.82 per share.IVL: Green Chemistry And AI Will Support Future Upside Potential
Analysts have slightly reduced their price target for Indorama Ventures to US$23.39 from about US$23.54, reflecting updated assumptions for more moderate revenue growth, a marginally lower profit margin outlook, and a slightly higher future P/E multiple, while keeping the discount rate unchanged. Valuation Changes Fair Value: reduced slightly from US$23.54 to US$23.39 per share.IVL: Stronger Margins And Lower P/E Will Support Upside Potential
Analysts have trimmed their price target for Indorama Ventures to $28.10, reflecting slightly softer revenue growth assumptions, together with a modestly higher profit margin outlook and a lower forward P/E multiple. Valuation Changes Fair Value: Unchanged at THB 28.10 per share, indicating no adjustment to the overall valuation anchor.IVL: Sustainability Breakthroughs In Fragrance Solubilization Will Support Stronger Profit Margins
Analysts have modestly reduced their price target for Indorama Ventures from THB 29.0 to THB 28.1, citing a higher required discount rate despite stronger expectations for revenue growth and profit margins in the future. What's in the News Indorama Ventures unit Indovinya launched an Open Innovation Challenge targeting sustainable fragrance solubilization solutions for the personal care market, in partnership with AEVO (Key Developments).IVL: Higher Required Returns And Lower Margins Will Temper Future Upside
Analysts have trimmed their fair value estimate for Indorama Ventures from about $18.00 to roughly $15.30 per share. They cite a higher required discount rate, weaker expected profit margins, and a richer future earnings multiple that together temper the upside case despite slightly improved revenue trends.IVL: Green Chemistry and AI Solutions Will Accelerate Market Leadership
Analysts have revised their price target for Indorama Ventures slightly downward from $24.18 to $23.54. This change is based on updated expectations for revenue growth and profit margins.IVL: Sustainable Solutions Drive Renewed Confidence Amid Market Opportunity
Analysts have lowered their price target for Indorama Ventures from $24.64 to $24.18. They cited revised growth assumptions and a slightly higher discount rate in their updated models.
Indovinya And Indovida IPOs Plus PET Recycling Expansion To Boost Profits And Margins
Asset rationalization and restructuring initiatives aim to improve profitability by reducing costs and boosting operational efficiency.Desglose de ingresos y gastos
Cómo gana y gasta dinero Indorama Ventures. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 441,801 | -9,768 | 50,624 | 0 |
| 31 Dec 25 | 451,196 | -8,263 | 50,936 | 0 |
| 30 Sep 25 | 469,758 | -2,660 | 49,320 | 0 |
| 30 Jun 25 | 496,880 | -516 | 51,059 | 0 |
| 31 Mar 25 | 526,014 | -22,947 | 60,736 | 0 |
| 31 Dec 24 | 544,095 | -20,465 | 62,327 | 0 |
| 30 Sep 24 | 551,098 | -33,758 | 64,525 | 0 |
| 30 Jun 24 | 552,450 | -34,847 | 64,827 | 0 |
| 31 Mar 24 | 543,155 | -11,438 | 59,290 | 0 |
| 31 Dec 23 | 543,627 | -11,548 | 58,737 | 0 |
| 30 Sep 23 | 561,228 | -10,599 | 57,711 | 0 |
| 30 Jun 23 | 600,913 | -2,657 | 59,823 | 0 |
| 31 Mar 23 | 650,887 | 17,210 | 63,067 | 0 |
| 31 Dec 22 | 660,378 | 30,256 | 62,936 | 0 |
| 30 Sep 22 | 648,360 | 47,126 | 61,648 | 0 |
| 30 Jun 22 | 596,117 | 45,537 | 57,016 | 0 |
| 31 Mar 22 | 519,408 | 33,595 | 50,422 | 0 |
| 31 Dec 21 | 470,555 | 25,538 | 47,137 | 0 |
| 30 Sep 21 | 421,682 | 21,603 | 44,235 | 0 |
| 30 Jun 21 | 375,854 | 15,435 | 41,881 | 0 |
| 31 Mar 21 | 339,531 | 7,102 | 38,887 | 0 |
| 31 Dec 20 | 333,602 | 1,665 | 38,378 | 0 |
| 30 Sep 20 | 327,950 | -1,310 | 36,613 | 0 |
| 30 Jun 20 | 331,111 | -973 | 35,160 | 0 |
| 31 Mar 20 | 350,929 | 1,213 | 35,821 | 0 |
| 31 Dec 19 | 354,672 | 4,275 | 34,181 | 0 |
| 30 Sep 19 | 368,047 | 8,072 | 33,430 | 0 |
| 30 Jun 19 | 379,665 | 17,334 | 32,587 | 0 |
| 31 Mar 19 | 368,174 | 23,309 | 30,566 | 0 |
| 31 Dec 18 | 348,255 | 25,415 | 28,318 | 0 |
| 30 Sep 18 | 327,382 | 33,064 | 27,175 | 0 |
| 30 Jun 18 | 303,907 | 26,526 | 27,597 | 0 |
| 31 Mar 18 | 291,919 | 21,220 | 26,316 | 0 |
| 31 Dec 17 | 287,335 | 19,833 | 25,799 | 0 |
| 30 Sep 17 | 281,315 | 12,790 | 24,962 | 0 |
| 30 Jun 17 | 274,508 | 12,458 | 22,564 | 0 |
| 31 Mar 17 | 269,508 | 15,472 | 22,711 | 0 |
| 31 Dec 16 | 255,130 | 15,147 | 21,772 | 0 |
| 30 Sep 16 | 247,350 | 12,332 | 21,450 | 0 |
| 30 Jun 16 | 243,995 | 9,680 | 20,927 | 0 |
| 31 Mar 16 | 238,839 | 9,199 | 19,841 | 0 |
| 31 Dec 15 | 235,284 | 5,559 | 19,168 | 0 |
| 30 Sep 15 | 232,822 | 4,772 | 18,243 | 0 |
| 30 Jun 15 | 233,826 | 5,092 | 17,555 | 0 |
Ingresos de calidad: IVL actualmente no es rentable.
Margen de beneficios creciente: IVL actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: IVL no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 53.2% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de IVL en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: IVL no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (21%).
Rentabilidad financiera
Alta ROE: IVL tiene una rentabilidad financiera negativa (-5.98%), ya que actualmente no es rentable.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/27 02:20 |
| Precio de las acciones al final del día | 2026/05/27 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Indorama Ventures Public Company Limited está cubierta por 21 analistas. 14 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Komsun Suksumrun | BofA Global Research |
| Suppata Srisuk | Bualuang Securities PCL |
| Amornrat Cheevavichawalkul | CGS International |